These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6815860)

  • 21. [Study of attenuated strain of myxoma virus].
    Maral R
    C R Acad Hebd Seances Acad Sci D; 1970 Aug; 271(8):737-9. PubMed ID: 4992294
    [No Abstract]   [Full Text] [Related]  

  • 22. ATTENUATION OF THE MYXOMA VIRUS AND USE OF THE LIVING ATTENUATED VIRUS AS AN IMMUNIZING AGENT FOR MYXOMATOSIS.
    SAITO JK; MCKERCHER DG; CASTRUCCI G
    J Infect Dis; 1964 Dec; 114():417-28. PubMed ID: 14233132
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.
    Kerr PJ; Perkins HD; Inglis B; Stagg R; McLaughlin E; Collins SV; Van Leeuwen BH
    Virology; 2004 Jun; 324(1):117-28. PubMed ID: 15183059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection for resistance to myxomatosis in domestic rabbits (Oryctolagus cuniculus).
    Sobey WR
    J Hyg (Lond); 1969 Dec; 67(4):743-54. PubMed ID: 5261215
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental infection of specific pathogen-free New Zealand White rabbits with five strains of amyxomatous myxoma virus.
    Marlier D; Cassart D; Boucraut-Baralon C; Coignoul F; Vindevogel H
    J Comp Pathol; 1999 Nov; 121(4):369-84. PubMed ID: 10542126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
    Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate resistance to myxomatosis in wild rabbits in England.
    Ross J; Sanders MF
    J Hyg (Lond); 1977 Dec; 79(3):411-5. PubMed ID: 270526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of serological evidence of myxoma virus infection in humans exposed during an outbreak of myxomatosis.
    Jackson EW; Dorn CR; Saito JK; McKercher DG
    Nature; 1966 Jul; 211(5046):313-4. PubMed ID: 4381646
    [No Abstract]   [Full Text] [Related]  

  • 29. AN ATTENUATED LIVE VIRUS VACCINE FOR MYXOMATOSIS.
    MCKERCHER DG; SAITO JK
    Nature; 1964 May; 202():933-4. PubMed ID: 14190113
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune responses to myxoma virus.
    Kerr P; McFadden G
    Viral Immunol; 2002; 15(2):229-46. PubMed ID: 12081009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pathogenic myxoma virus in vaccinated and non-vaccinated commercial rabbits.
    Kritas SK; Dovas C; Fortomaris P; Petridou E; Farsang A; Koptopoulos G
    Res Vet Sci; 2008 Dec; 85(3):622-4. PubMed ID: 18455207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and testing of a novel host-range defective myxoma virus vaccine with the M063 gene inactivated that is non-permissive for replication in rabbit cells.
    Adams MM; van Leeuwen BH; McFadden G; Kerr PJ
    Vet Res; 2008; 39(6):60. PubMed ID: 18778680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses.
    Camus-Bouclainville C; Gretillat M; Py R; Gelfi J; Guérin JL; Bertagnoli S
    Emerg Infect Dis; 2011 Apr; 17(4):633-8. PubMed ID: 21470452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myxomatosis on the Western Plains of Victoria.
    Tighe FG; Edmonds JW; Nolan IF; Shepherd RC; Gocs A
    J Hyg (Lond); 1977 Oct; 79(2):209-17. PubMed ID: 20473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectious agents associated with rabbit pneumonia: isolation of amyxomatous myxoma virus strains.
    Marlier D; Mainil J; Linde A; Vindevogel H
    Vet J; 2000 Mar; 159(2):171-8. PubMed ID: 10712805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restriction by polycations of infection with myxoma virus in rabbits.
    Wegner DL; Hinze HC
    J Infect Dis; 1972 Feb; 125(2):141-5. PubMed ID: 4550228
    [No Abstract]   [Full Text] [Related]  

  • 37. Impact of viral hemorrhagic disease on a wild population of European rabbits in France.
    Marchandeau S; Chantal J; Portejoie Y; Barraud S; Chaval Y
    J Wildl Dis; 1998 Jul; 34(3):429-35. PubMed ID: 9706551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vaccination against myxomatosis and reactivity of rabbits in the pharmacopeial test for pyrogenity].
    Benesová O; Voldan M; Votavová M; Nobilis M
    Cesk Farm; 1973 Mar; 22(2):78-9. PubMed ID: 4694129
    [No Abstract]   [Full Text] [Related]  

  • 39. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits.
    Best SM; Kerr PJ
    Virology; 2000 Feb; 267(1):36-48. PubMed ID: 10648181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies in the epidemiology of infectious myxomatosis of rabbits. VII. The virulence of strains of myxoma virus recovered from Australian wild rabbits between 1951 and 1959.
    MARSHALL ID; FENNER F
    J Hyg (Lond); 1960 Dec; 58(4):485-8. PubMed ID: 13767209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.